Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28688636)

Published in J Surg Res on March 31, 2017

Authors

Aslam Ejaz1, Leigh Casadaban2, Ajay V Maker3

Author Affiliations

1: Division of Surgical Oncology, Department of Surgery, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; Department of Surgery, Johns Hopkins University, Baltimore, Maryland.
2: Division of Surgical Oncology, Department of Surgery, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; Creticos Cancer Center at Advocate Illinois Masonic Medical Center, Chicago, Illinois.
3: Division of Surgical Oncology, Department of Surgery, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; Creticos Cancer Center at Advocate Illinois Masonic Medical Center, Chicago, Illinois. Electronic address: amaker@uic.edu.

Articles cited by this

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med (1990) 11.57

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet (2007) 9.23

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. N Engl J Med (2016) 8.53

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol (2004) 7.36

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol (2004) 7.16

Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet (1995) 5.68

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol (1993) 4.09

Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol (1999) 3.89

Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol (2011) 3.22

Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst (2008) 2.46

Oxaliplatin as part of adjuvant therapy for colon cancer: more complicated than once thought. J Clin Oncol (2012) 2.45

Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol (1995) 2.02

Dilemma of stage II colon cancer and decision making for adjuvant chemotherapy. J Am Coll Surg (2014) 1.70

Colon cancer, version 3.2014. J Natl Compr Canc Netw (2014) 1.59

Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis. Ann Surg Oncol (2014) 1.53

Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials. Ann Surg Oncol (2010) 1.27

Adequacy and importance of lymph node evaluation for colon cancer in the elderly. J Am Coll Surg (2007) 1.20

Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncol (2005) 1.13

Ongoing challenge of stage II colon cancer. J Clin Oncol (2011) 1.04

Adjuvant therapy for stage II colon cancer: an elephant in the living room? Ann Oncol (2004) 1.00

Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer. Pancreas (2009) 1.00

Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study. Onkologie (2005) 0.97

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer. Br J Cancer (2007) 0.96

Postoperative adjuvant chemotherapy for stage II colorectal cancer: a systematic review of 12 randomized controlled trials. J Gastrointest Surg (2011) 0.95

Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors. Ann Surg Oncol (2013) 0.95

Oncotype DX(®) colon cancer assay for prediction of recurrence risk in patients with stage II and III colon cancer: A review of the evidence. Surg Oncol (2015) 0.90

Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched Surveillance, Epidemiology, and End Results analysis. Surgery (2013) 0.88

Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer. Cancer (2014) 0.86

Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer. Cancer (2016) 0.77

Randomized trial of the efficacy of adjuvant chemotherapy for colon cancer with combination therapy incorporating the oral pyrimidine 1-hexylcarbamoyl-5-fluorouracil. Langenbecks Arch Surg (2006) 0.77